ClinConnect ClinConnect Logo
Search / Trial NCT04148443

Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.

Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Oct 31, 2019

Trial Information

Current as of August 02, 2025

Withdrawn

Keywords

Preoxygenation Intubation End Tidal Of Oxygen Concentration Intensive Care Unit Critically Ill Patients

ClinConnect Summary

This is a multicenter randomized controlled pilot study. 110 patients who require intubation in the ICU will be randomly assigned, with a 1:1 ratio, to 3 or 5 minutes of preoxygenation duration. EtO2 will be continuously measured but hidden to the clinician. The primary outcome measure will be the obtention of an optimal preoxygenation defined by an EtO2 \>90%. Secondary outcomes include the occurrence of hypoxia and complications during the procedure.

A pulse oximetry (SpO2) greater than or equal to 96% (SpO2 ≥ 96%) at the end of preoxygenation will be the target in each group. If at the ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients older than 18 years
  • Requiring intubation in ICU
  • Free express oral and informed consent of the patient or a proxy in case of impossibility for the patient to consent; emergency inclusion possible when legal representatives and patient's family are not present
  • Exclusion Criteria:
  • Intubation for cardiac arrest
  • End-tidal oxygen concentration monitoring not available
  • Preoxygenation with high-flow nasal oxygenation
  • Previous participation to the study
  • Patient known, at time of inclusion, as being under guardianship, tutorship or curator
  • Pregnancy or breastfeeding
  • Lack of social security number

About Centre Hospitalier Régional D'orléans

The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.

Locations

Tours, , France

Dax, , France

Orléans, , France

Patients applied

0 patients applied

Trial Officials

Mai-ANh NAY, MD

Principal Investigator

CHR Orléans

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials